Can we avoid axillary dissection in the micrometastatic sentinel node in breast cancer?

Breast Cancer Research and Treatment

Volumn 131, Issue 3, 2012, Pages 819-825

  Galimberti, Viviana ^a   Botteri, Edoardo ^a   Chifu, Camelia ^a   Gentilini, Oreste ^a   Luini, Alberto ^a   Intra, Mattia ^a   Baratella, Paola ^a   Sargenti, Manuela ^a   Zurrida, Stefano ^a,b   Veronesi, Paolo ^a,b   Rotmensz, Nicole ^a   Viale, Giuseppe ^a,b   Sonzogni, Angelica ^a   Colleoni, Marco ^a   Veronesi, Umberto ^a  

^a EUROPEAN INSTITUTE OF ONCOLOGY   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

Author keywords

Axillary dissection; Breast cancer; Micrometastasis; Sentinel node

Indexed keywords

ADULT; AGED; ARTICLE; AXILLARY DISSECTION; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER HORMONE THERAPY; CANCER INCIDENCE; CANCER PATIENT; CANCER PROGNOSIS; CANCER RECURRENCE; CANCER RISK; CANCER SURGERY; CANCER SURVIVAL; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; MICROMETASTASIS; OUTCOME ASSESSMENT; PRIORITY JOURNAL; SENTINEL LYMPH NODE; SURGICAL TECHNIQUE; TUMOR VOLUME;

ADULT; AGED; AXILLA; BREAST NEOPLASMS; FEMALE; HUMANS; INCIDENCE; LYMPH NODES; LYMPHATIC METASTASIS; MIDDLE AGED; NEOPLASM GRADING; NEOPLASM MICROMETASTASIS; NEOPLASM STAGING; RETROSPECTIVE STUDIES; SENTINEL LYMPH NODE BIOPSY; SURVIVAL ANALYSIS;

EID: 84856224710     PISSN: 01676806     EISSN: 15737217     Source Type: Journal    
DOI: 10.1007/s10549-011-1486-2     Document Type: Article

References (28)

1. Veronesi U, Galimberti V, Paganelli G, Maisonneuve P, Viale G, Orecchia R, Luini A, Intra M, Veronesi P, Caldarella P, Renne G, Rotmensz N, Sangalli C, De Brito Lima L, Tullii M, Zurrida S.(2009) Axillary metastases in breast cancer patients with negative sentinel nodes: a follow-up of 3548 cases. Eur J Cancer. doi: 10.1016/j.ejca.2008.11.041
2. Veronesi U, Viale G, Paganelli G, Zurrida S, Luini A, Galimberti V, Veronesi P, Intra M, Maisonneuve P, Zucca F, Gatti G, Mazzarol G, De Cicco C, Vezzoli D (2010) Sentinel lymph node biopsy in breast cancer: ten-year results of a randomized controlled study. Ann Surg. doi: 10.1097/SLA.0b013e3181c0e92a
3. Mansel RE, Goyal A (2004) European studies on breast lymphatic mapping. Semin Oncol. doi: 10.1053/j.seminoncol.2004.03.003
4. Dabbs DJ, Fung M, Landsittel D, McManus K, Johnson R (2004) Sentinel lymph node micrometastasis as a predictor of axillary tumor burden. Breast J. doi: 10.1111/j.1075-122X.2004.21280.x
5. Noguchi M (2008) Avoidance of axillary lymph node dissection in selected patients with node-positive breast cancer. Eur J Surg Oncol. doi: 10.1016/j.ejso.2007.03.026
6. U Veronesi G Paganelli G Viale A Luini S Zurrida V Galimberti M Intra P Veronesi C Robertson P Maisonneuve G Renne C De Cicco F De Lucia R Gennari 2003 A randomized comparison of sentinel-node biopsy with routine axillary dissection in breast cancer N Engl J Med 349 546 553 12904519 10.1056/NEJMoa012782
7. N Wasif MA Maggard CY Ko AE Giuliano 2010 Underuse of axillary dissection for the management of sentinel node micrometastases in breast cancer Arch Surg 145 161 166 20157084 10.1001/archsurg.2009.269
8. Olson JA Jr, McCall LM, Beitsch P, Whitworth PW, Reintgen DS, Blumencranz PW, Leitch AM, Saha S, Hunt KK, Giuliano AE; American College of Surgeons Oncology Group Trials Z0010 and Z0011 (2008) Impact of immediate versus delayed axillary node dissection on surgical outcomes in breast cancer patients with positive sentinel nodes: results from American College of Surgeons Oncology Group Trials Z0010 and Z0011. J Clin Oncol. doi: 10.1200/JCO.2007.15.5630
9. Lucci A, McCall LM, Beitsch PD, Whitworth PW, Reintgen DS, Blumencranz PW, Leitch AM, Saha S, Hunt KK, Giuliano AE; American College of Surgeons Oncology Group (2007) Surgical complications associated with sentinel lymph node dissection (SLND) plus axillary lymph node dissection compared with SLND alone in the American College of Surgeons Oncology Group Trial Z0011. J Clin Oncol 20. doi: 10.1200/JCO.2006.07.4062
10. Straver ME, Meijnen P, van Tienhoven G, van de Velde CJ, Mansel RE, Bogaerts J, Duez N, Cataliotti L, Klinkenbijl JH, Westenberg HA, van der Mijle H, Snoj M, Hurkmans C, Rutgers EJ (2010) Sentinel node identification rate and nodal involvement in the EORTC 10981-22023 AMAROS trial. Ann Surg Oncol. doi: 10.1245/s10434-010-0945-z
11. van Deurzen CH, de Boer M, Monninkhof EM, Bult P, van der Wall E, Tjan-Heijnen VC, van Diest PJ (2008) Non-sentinel lymph node metastases associated with isolated breast cancer cells in the sentinel node. J Natl Cancer Inst. doi: 10.1093/jnci/djn343
12. Naik AM, Fey J, Gemignani M, Heerdt A, Montgomery L, Petrek J, Port E, Sacchini V, Sclafani L, VanZee K, Wagman R, Borgen PI, Cody HS 3rd (2004) The risk of axillary relapse after sentinel lymph node biopsy for breast cancer is comparable with that of axillary lymph node dissection: a follow-up study of 4008 procedures. Ann Surg. doi: 10.1097/01.sla.0000137130.23530.19
13. Smidt ML, Janssen CM, Kuster DM, Bruggink ED, Strobbe LJ (2005) Axillary recurrence after a negative sentinel node biopsy for breast cancer: incidence and clinical significance. Ann Surg Oncol. doi: 10.1007/s10434-004-1166-0
14. AE Giuliano DM Kirgan JM Guenther DL Morton 1994 Lymphatic mapping and sentinel lymphadenectomy for breast cancer Ann Surg 220 391 398 8092905 10.1097/00000658-199409000-00015 1:STN:280:DyaK2cznvFyksA%3D%3D
15. D Krag D Weaver T Ashikaga F Moffat VS Klimberg C Shriver S Feldman R Kusminsky M Gadd J Kuhn S Harlow P Beitsch 1998 The sentinel node in breast cancer-a multicenter validation study N Engl J Med 339 941 946 9753708 10.1056/NEJM199810013391401 1:STN:280:DyaK1cvhvVKntg%3D%3D
16. Veronesi U, Orecchia R, Zurrida S, Galimberti V, Luini A, Veronesi P, Gatti G, D'Aiuto G, Cataliotti L, Paolucci R, Piccolo P, Massaioli N, Sismondi P, Rulli A, Lo Sardo F, Recalcati A, Terribile D, Acerbi A, Rotmensz N, Maisonneuve P (2005) Avoiding axillary dissection in breast cancer surgery: a randomized trial to assess the role of axillary radiotherapy. Ann Oncol. doi: 10.1093/annonc/mdi089
17. Straver ME, Meijnen P, van Tienhoven G, van de Velde CJ, Mansel RE, Bogaerts J, Demonty G, Duez N, Cataliotti L, Klinkenbijl J, Westenberg HA, van der Mijle H, Hurkmans C, Rutgers EJ (2010) Role of axillary clearance after a tumor-positive sentinel node in the administration of adjuvant therapy in early breast cancer. J Clin Oncol. doi: 10.1200/JCO.2008.21.7554
18. G Viale E Maiorano G Mazzarol S Zurrida V Galimberti A Luini G Renne G Pruneri P Maisonneuve U Veronesi 2001 Histologic detection and clinical implications of micrometastases in axillary sentinel lymph nodes for patients with breast carcinoma Cancer 92 1378 1384 11745213 10.1002/1097-0142(20010915) 92:6<1378::AID-CNCR1460>3.0.CO;2-Y 1:STN:280:DC%2BD3MnpvV2lsQ%3D%3D
19. Colleoni M, Rotmensz N, Peruzzotti G, Maisonneuve P, Mazzarol G, Pruneri G, Luini A, Intra M, Veronesi P, Galimberti V, Torrisi R, Cardillo A, Goldhirsch A, Viale G (2005) Size of breast cancer metastases in axillary lymph nodes: clinical relevance of minimal lymph node involvement. J Clin Oncol. doi: 10.1200/JCO.2005.07.094
20. Goldhirsch A, Ingle JN, Gelber RD, Coates AS, Thürlimann B, Senn HJ; Panel members (2009) Thresholds for therapies: highlights of the St Gallen International Expert Consensus on the primary therapy of early breast cancer. Ann Oncol. doi: 10.1093/annonc/mdp322
21. A Goldhirsch WC Wood RD Gelber AS Coates B Thürlimann HJ Senn 2007 10th St. Gallen conference. Progress and promise: highlights of the international expert consensus on the primary therapy of early breast cancer 2007 Ann Oncol 18 1133 1144 17675394 10.1093/annonc/mdm271 1:STN:280: DC%2BD2svlvVSkuw%3D%3D
22. Galimberti V (2006) International Breast Cancer Study Group Trial of sentinel node biopsy. J Clin Oncol. doi: 10.1200/JCO.2005.04.5658
23. Giuliano AE, McCall L, Beitsch P, Whitworth PW, Blumencranz P, Leitch AM, Saha S, Hunt KK, Morrow M, Ballman K (2010) Locoregional recurrence after sentinel lymph node dissection with or without axillary dissection in patients with sentinel lymph node metastases: the American College of Surgeons Oncology Group Z0011 randomized trial. Ann Surg. doi: 10.1097/SLA.0b013e3181f08f32
24. The EORTC 10981-22023 AMAROS trial website: http://research.nki.nl/ amaros/. Accessed 01/09/2010
25. Marubini E, Valsecchi MG (1995) Analyzing survival data from clinical trials and observational studies. Wiley, Chichester, England, p 331
26. The R Development Core Team (2004) Free Software Foundation, Boston, MA. http://www.forestencyclopedia.net/c/c12582
27. Truong PT, Lesperance M, Li KH, MacFarlane R, Speers CH, Chia S (2010) Micrometastatic node-positive breast cancer: long-term outcomes and identification of high-risk subsets in a large population-based series. Ann Surg Oncol. doi: 10.1245/s10434-010-0954-y
28. Montagna E, Viale G, Rotmensz N, Maisonneuve P, Galimberti V, Luini A, Intra M, Veronesi P, Mazzarol G, Pruneri G, Renne G, Torrisi R, Cardillo A, Cancello G, Goldhirsch A, Colleoni M (2009) Minimal axillary lymph node involvement in breast cancer has different prognostic implications according to the staging procedure. Breast Cancer Res Treat. doi: 10.1007/s10549-009-0446-6